Chapter 162 Bronchopulmonary Disease
Diseases of the tracheobronchial tree and pulmonary parenchyma are very common in canine and feline patients and are responsible for substantial morbidity in the pet animal population. Determining the underlying disease responsible requires an understanding of clinical signs, interpretation of laboratory and radiographic findings, and collection and analysis of airway samples. Individualized therapy will be most likely to lead to amelioration of signs. Many respiratory tract diseases are chronic in nature, and the goals of therapy become controlling clinical signs and avoiding progression of disease.
CLINICAL SIGNS
Overview in Dogs
Overview in Cats
TRACHEAL COLLAPSE
Etiology
Pathophysiology
Clinical Signs
Signalment
Small-breed dogs are typically affected with tracheal collapse, and an increased prevalence is generally seen in the Yorkshire terrier, poodle, Pomeranian, and chihuahua. Any breed of dog can be affected by lower-airway collapse, although typically smaller breed dogs are affected. Animals of any age may present with signs related to tracheal and/or lower-airway collapse.
History
Physical Examination
Diagnosis
Radiography
Transtracheal Wash
Bronchoscopy
Treatment
General
Antitussives
Bronchodilators
Dogs that have intrathoracic airway collapse and evidence of small airway disease may benefit from the use of bronchodilators (Table 162-1). Bronchodilators have no clinically significant effect on the large airways and do not result in an increased diameter in the tracheal lumen. Instead, these drugs act primarily on small airways, making it easier for air to flow out of the lungs and lessening the tendency for dynamic collapse of large airways.
Drug | Dosage | Side effects |
---|---|---|
Methylxanthines | ||
Sustained-release theophylline | Dog: 10 mg/kg PO q12h | Multiple drug interactions, gastrointestinal upset, tachycardia |
Cat: 10 mg/kg PO q24h (PM) | ||
Beta agonists | ||
Terbutaline | Dog and cat: 0.01 mg/kg SC, IV | Tachycardia, hypotension |
Dog: 1.25–5.0 mg/dog PO q12h | ||
Cat: 0.625 mg PO q12h | ||
Terbutaline MDI | 200 μg/puff q12h by aerosol | |
Albuterol | Dog: 50 μg/kg PO q12h | |
Albuterol MDI | 90 μg/puff q12h by aerosol | |
Epinephrine | 20 μg/kg IV, IM, SC, IT | Cardiac arrhythmias, hypertension, vasoconstriction |
MDI, metered dose inhaler